Literature DB >> 19422768

Outbreak of Clostridium difficile 027 infection in Vienna, Austria 2008-2009.

A Indra1, S Huhulescu, A Fiedler, S Kernbichler, M Blaschitz, F Allerberger.   

Abstract

From November 2008 to 15 April 2009, 36 isolates of CD027 identified in Austria, all originating from four hospitals in Vienna. All isolates were positive for toxin A, toxin B and the binary toxin, and showed a characteristic 18 bp deletion in the tcdC gene. Clostridium difficile is an anaerobic spore-forming bacterium. Some strains may cause diarrhoea due to formation of toxins. Symptomatic C. difficile infection (CDI) is primarily linked with hospital admission and antibiotic treatment, although antibiotic exposure is neither necessary nor sufficient for CDI [1,2]. In Belgium, for instance, one third of CDI cases reported in the hospital surveillance system are not hospital-associated [3]. Symptoms range from mild diarrhoea to serious manifestations such as pseudomembranous colitis, toxic megacolon or perforation of the colon. C. difficile challenges hygiene standards as it is forms spores. The risk of infection rises with increasing age, underlying disease and immunodeficiency [4]. In recent years, a particularly virulent strain, ribotype 027 (CD027), has emerged in a number of countries, particularly in connection with hospital outbreaks, but also in community-acquired diarrhoea cases [5]. The risk of serious disease and death associated with CD027 exceeds that of other C. difficile strains. The classical CD027 is characterised - among other things - by an increased production of toxins A and B, production of a binary toxin and resistance to newer fluoroquinolones such as moxifloxacin. The first three Austrian cases of CD027 occurred in 2006 and in March 2008 [6,7]. Since August 2006, the Austrian National Reference Centre for C. difficile has ribotyped approximately 2,700 human C. difficile isolates received from all nine Austrian provinces. In recent months, a drastic increase in CD027 cases has been noted, all originating from four hospitals in Vienna. From November 2008 to 15 April 2009, 36 isolates of CD027 were received at the National Reference Centre. The Figure summarises these C. difficile 027 cases by month of reception of the sample at the reference centre.

Entities:  

Mesh:

Year:  2009        PMID: 19422768

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  12 in total

1.  Hospital-acquired Clostridium difficile infection: determinants for severe disease.

Authors:  J M Wenisch; D Schmid; H-W Kuo; E Simons; F Allerberger; V Michl; P Tesik; G Tucek; C Wenisch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-31       Impact factor: 3.267

Review 2.  The changing epidemiology of Clostridium difficile infections.

Authors:  J Freeman; M P Bauer; S D Baines; J Corver; W N Fawley; B Goorhuis; E J Kuijper; M H Wilcox
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

3.  Severe Clostridium difficile infection: incidence and risk factors at a tertiary care university hospital in Vienna, Austria.

Authors:  Peter Starzengruber; Luigi Segagni Lusignani; Thomas Wrba; Dieter Mitteregger; Alexander Indra; Wolfgang Graninger; Elisabeth Presterl; Magda Diab-Elschahawi
Journal:  Wien Klin Wochenschr       Date:  2014-06-06       Impact factor: 1.704

4.  Clostridium difficile infection: monoclonal or polyclonal genesis?

Authors:  M Hell; M Permoser; G Chmelizek; J M Kern; M Maass; S Huhulescu; A Indra; F Allerberger
Journal:  Infection       Date:  2011-08-09       Impact factor: 3.553

5.  Effect of airborne hydrogen peroxide on spores of Clostridium difficile.

Authors:  Georg Steindl; Anita Fiedler; Steliana Huhulescu; Günther Wewalka; Franz Allerberger
Journal:  Wien Klin Wochenschr       Date:  2014-12-20       Impact factor: 1.704

Review 6.  Controversies Around Epidemiology, Diagnosis and Treatment of Clostridium difficile Infection.

Authors:  Fawziah Marra; Karen Ng
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

7.  A prospective cohort study on hospital mortality due to Clostridium difficile infection.

Authors:  J M Wenisch; D Schmid; G Tucek; H-W Kuo; F Allerberger; V Michl; P Tesik; H Laferl; C Wenisch
Journal:  Infection       Date:  2012-04-17       Impact factor: 3.553

8.  Epidemiology of Clostridium difficile infection: results of a hospital-based study in Krakow, Poland.

Authors:  J Czepiel; J Kędzierska; G Biesiada; M Birczyńska; W Perucki; P Nowak; A Garlicki
Journal:  Epidemiol Infect       Date:  2015-04-10       Impact factor: 4.434

Review 9.  Prediction tools for unfavourable outcomes in Clostridium difficile infection: a systematic review.

Authors:  Claire Nour Abou Chakra; Jacques Pepin; Louis Valiquette
Journal:  PLoS One       Date:  2012-01-24       Impact factor: 3.240

10.  Clostridium difficile ribotypes in Austria: a multicenter, hospital-based survey.

Authors:  Alexander Indra; Daniela Schmid; Steliana Huhulescu; Erica Simons; Markus Hell; Karl Stickler; Franz Allerberger
Journal:  Wien Klin Wochenschr       Date:  2015-07-09       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.